戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 y segment that was found to disrupt receptor bioluminescence resonance energy transfer.
2  strong interaction between PAR1 and PAR4 by bioluminescence resonance energy transfer.
3  by increased intramolecular fluorescence or bioluminescence resonance energy transfer.
4 eceptor kinase (GRK) 2/5/6, as determined by bioluminescence resonance energy transfer.
5 riate fluorophores in a manner distinct from bioluminescence resonance energy transfer.
6 lphas, and beta-arrestin1 were studied using bioluminescence resonance energy transfer 2 (BRET(2)) in
7                                         This Bioluminescence resonance energy transfer(2) (BRET(2)) s
8  to form a functional carrier as assessed by bioluminescence resonance energy transfer; 3) in MPC1 de
9                                  Our in vivo bioluminescence resonance energy transfer analyses in Ar
10 homodimers and heterodimers was confirmed by bioluminescence resonance energy transfer analyses.
11                                              Bioluminescence resonance energy transfer analysis revea
12                                    In planta bioluminescence resonance energy transfer analysis was u
13                                        Using bioluminescence resonance energy transfer analysis, fibr
14 in in these proteins, using a combination of bioluminescence resonance energy transfer and amide hydr
15 e now use competitive inhibition of receptor bioluminescence resonance energy transfer and bimolecula
16 odimers, as demonstrated by experiments with bioluminescence resonance energy transfer and bimolecula
17                                              Bioluminescence resonance energy transfer and co-immunop
18 ing an energy transfer relay that integrates bioluminescence resonance energy transfer and fluorescen
19 y, this powerful convergence of results from bioluminescence resonance energy transfer and hydrogen/d
20                                              Bioluminescence resonance energy transfer and intracellu
21                                     By using bioluminescence resonance energy transfer and superresol
22 e use morphological fluorescence techniques, bioluminescence resonance energy transfer, and bimolecul
23 sfer (FRET), spectrofluorometric analysis of bioluminescence resonance energy transfer, and coimmunop
24 n vitro and in vivo, yeast two-hybrid assay, bioluminescence resonance energy transfer, and confocal
25           A suite of co-immunoprecipitation, bioluminescence resonance energy transfer, and pharmacol
26                                      Using a bioluminescence resonance energy transfer approach to mo
27                      Using cross-linking and bioluminescence resonance energy transfer approaches, we
28 e in close proximity in live cells using the bioluminescence resonance energy transfer assay.
29                                      A BRET (bioluminescence resonance energy transfer) assay reveale
30                                              Bioluminescence resonance energy transfer assays for Gi
31                                              Bioluminescence resonance energy transfer assays further
32  expressed in islets, time-resolved FRET and bioluminescence resonance energy transfer assays illustr
33                   Using our highly optimized bioluminescence resonance energy transfer assays in conj
34                           Furthermore, using bioluminescence resonance energy transfer assays to dire
35                    Coimmunoprecipitation and bioluminescence resonance energy transfer assays with tr
36 T was detected by co-immunoprecipitation and bioluminescence resonance energy transfer assays.
37 -fused Galpha constructs that can be used in bioluminescence resonance energy transfer assays.
38 d in OXE-R-overexpressing HEK293 cells using bioluminescence resonance energy transfer assays.
39          Here, using an intramolecular BRET (bioluminescence resonance energy transfer)-based biosens
40 ocal microscopy or with a recently developed bioluminescence resonance energy transfer-based approach
41                                      Using a bioluminescence resonance energy transfer-based assay (C
42                                      Using a bioluminescence resonance energy transfer-based assay (C
43 ith measuring changes in the GAP activity by bioluminescence resonance energy transfer-based assay in
44 7 and RGS9-2 complexes in live cells using a bioluminescence resonance energy transfer-based assay th
45                          We also developed a bioluminescence resonance energy transfer-based assay to
46  a large panel of G protein subtypes using a bioluminescence resonance energy transfer-based assay wi
47               Importantly, by using a robust bioluminescence resonance energy transfer-based assay, w
48 gic receptors (beta(2)AR) was assessed using bioluminescence resonance energy transfer-based assays i
49                   Here, we describe a unique bioluminescence resonance energy transfer-based AtAtg8 s
50                                        Using bioluminescence resonance energy transfer-based biosenso
51                                        Using bioluminescence resonance energy transfer-based biosenso
52 eceptor signaling to NF-kappaB, we developed bioluminescence resonance energy transfer-based interact
53 ors, which demonstrate the usefulness of the bioluminescence resonance energy transfer-based measurem
54   Here, integrin clustering should stimulate bioluminescence resonance energy transfer between a cell
55 eter proximity in living cells, we monitored bioluminescence resonance energy transfer between GFP an
56 vator, to the Golgi apparatus, determined by bioluminescence resonance energy transfer between Ggamma
57                                 By combining bioluminescence resonance energy transfer, bifunctional
58                                 By combining bioluminescence resonance energy transfer, bimolecular c
59                                    We used a bioluminescence resonance energy transfer biosensor to s
60 ous ligands with G protein subtypes by using bioluminescence resonance energy transfer biosensors mon
61                               In this study, bioluminescence resonance energy transfer (BRET(2)) anal
62                                        Using bioluminescence resonance energy transfer (BRET(2)), we
63 as nonradiatively transferred to PbS QDs via bioluminescence resonance energy transfer (BRET) and ena
64         Using two cellular assays based on a bioluminescence resonance energy transfer (BRET) approac
65 tification technology on the live cell-based bioluminescence resonance energy transfer (BRET) assay p
66  The E2-induced interaction was confirmed by bioluminescence resonance energy transfer (BRET) assays
67                            Here, we describe bioluminescence resonance energy transfer (BRET) assays
68 show that in conventional, competition-based bioluminescence resonance energy transfer (BRET) assays
69                                  Multiplexed bioluminescence resonance energy transfer (BRET) assays
70                               In particular, bioluminescence resonance energy transfer (BRET) assays
71 ouple to dopamine D1R receptors by real-time bioluminescence resonance energy transfer (BRET) assays.
72 ction of several of the mutants was shown by bioluminescence resonance energy transfer (BRET) assays.
73 o arrestin-3-JNK3 interaction assay based on bioluminescence resonance energy transfer (BRET) between
74  activity of the kinase in swimming cells by bioluminescence resonance energy transfer (BRET) between
75                                              Bioluminescence resonance energy transfer (BRET) between
76           We investigated the possibility of bioluminescence resonance energy transfer (BRET) between
77                     Due to an intramolecular bioluminescence resonance energy transfer (BRET) between
78 ditional signaling investigation approaches, bioluminescence resonance energy transfer (BRET) biosens
79 yonic kidney 293 cells were transfected with bioluminescence resonance energy transfer (BRET) donor/a
80                                              Bioluminescence resonance energy transfer (BRET) experim
81  AGS4, with Galpha(il) in the intact cell by bioluminescence resonance energy transfer (BRET) in huma
82                                        Using bioluminescence resonance energy transfer (BRET) in live
83 ular fluorescence complementation (BiFC) and bioluminescence resonance energy transfer (BRET) in live
84                                        Using bioluminescence resonance energy transfer (BRET) in live
85                                              Bioluminescence resonance energy transfer (BRET) is a na
86                                              Bioluminescence resonance energy transfer (BRET) is a we
87                                              Bioluminescence resonance energy transfer (BRET) is curr
88                                              Bioluminescence resonance energy transfer (BRET) is ofte
89 actin receptors and luciferase/GFP such that bioluminescence resonance energy transfer (BRET) occurre
90                                              Bioluminescence resonance energy transfer (BRET) operate
91                      Taking advantage of the bioluminescence resonance energy transfer (BRET) phenome
92                                            A bioluminescence resonance energy transfer (BRET) readout
93 ecular fluorescein arsenical hairpin (FlAsH) bioluminescence resonance energy transfer (BRET) reporte
94 e from Forster resonance energy transfer and bioluminescence resonance energy transfer (BRET) studies
95                                 We conducted bioluminescence resonance energy transfer (BRET) studies
96  salmeterol-mediated desensitization through bioluminescence resonance energy transfer (BRET) studies
97 s: a modified mammalian two-hybrid system, a bioluminescence resonance energy transfer (BRET) system,
98                In the present study, we used bioluminescence resonance energy transfer (BRET) techniq
99            We present the general use of the bioluminescence resonance energy transfer (BRET) technol
100  factor receptor (EGFR) activation using the bioluminescence resonance energy transfer (BRET) technol
101 red light-emitting reporter systems based on bioluminescence resonance energy transfer (BRET) that al
102 sent a new sensor platform (LUMABS) based on bioluminescence resonance energy transfer (BRET) that al
103                           We previously used bioluminescence resonance energy transfer (BRET) to demo
104                                  We utilized bioluminescence resonance energy transfer (BRET) to dete
105                                      We used bioluminescence resonance energy transfer (BRET) to exam
106 e describe a broadly applicable method using bioluminescence resonance energy transfer (BRET) to reve
107                                  Here we use bioluminescence resonance energy transfer (BRET) to show
108                                 We have used bioluminescence resonance energy transfer (BRET) to stud
109                                              Bioluminescence resonance energy transfer (BRET) was ass
110 Bimolecular fluorescence complementation and bioluminescence resonance energy transfer (BRET) were us
111 e-scanning mutagenesis of 14 TM IV residues, bioluminescence resonance energy transfer (BRET), and fu
112                          A sister technique, bioluminescence resonance energy transfer (BRET), avoids
113                          This method, called bioluminescence resonance energy transfer (BRET), uses a
114 robing the receptor for ubiquitination using bioluminescence resonance energy transfer (BRET), we det
115                                              Bioluminescence resonance energy transfer (BRET), which
116 e of them for their functional efficacies in bioluminescence resonance energy transfer (BRET)-based a
117 ral GPCRs in intact cells was monitored by a bioluminescence resonance energy transfer (BRET)-based a
118          Here we developed an intramolecular bioluminescence resonance energy transfer (BRET)-based b
119 operties and high affinity, as determined by bioluminescence resonance energy transfer (BRET)-based s
120 ated emission peaks produced by a sequential bioluminescence resonance energy transfer (BRET)-fluores
121 f AGS4 with Galpha(i1) in living cells using bioluminescence resonance energy transfer (BRET).
122 low fluorescent protein was quantified using bioluminescence resonance energy transfer (BRET).
123 (++) sensor that is ratiometric by virtue of bioluminescence resonance energy transfer (BRET).
124 eceptors in the intact cell as determined by bioluminescence resonance energy transfer (BRET).
125 llular proliferation, Ca2+ mobilization, and bioluminescence resonance energy transfer (BRET-2) assay
126                   The analysis was made with bioluminescence resonance energy transfer, co-immunoprec
127                                        Using bioluminescence resonance energy transfer, coimmunopreci
128                                Guided by the bioluminescence resonance energy transfer data, molecula
129                                              Bioluminescence resonance energy transfer demonstrated t
130                             We used in vitro bioluminescence resonance energy transfer, ex vivo analy
131                      Immunoprecipitation and bioluminescence resonance energy transfer experiments de
132                                              Bioluminescence resonance energy transfer experiments pr
133 ing alanine-scanning mutagenesis, in cellulo bioluminescence resonance energy transfer experiments, a
134  of the Go protein by GluK1 was validated in bioluminescence resonance energy transfer experiments, w
135    Using a unique combination of single-cell bioluminescence resonance energy transfer imaging in liv
136                                        Using bioluminescence resonance energy transfer, immunofluores
137                                        Using bioluminescence resonance energy transfer, immunofluores
138 ent quantum dot conjugates that luminesce by bioluminescence resonance energy transfer in the absence
139 ammalian cells exhibited saturable, specific bioluminescence resonance energy transfer indicating com
140 m is transferred to the quantum dots through bioluminescence resonance energy transfer, leading to qu
141                                              Bioluminescence resonance energy transfer measurements i
142 arrestin2, Rab5, Rab7, and Rab11 proteins in bioluminescence resonance energy transfer measurements t
143 /heteromers was confirmed in living cells by bioluminescence resonance energy transfer measurements,
144 ompartments in response to stimulation using bioluminescence resonance energy transfer measurements.
145 ed using enzyme-fragment complementation and bioluminescence resonance energy transfer methods.
146                            Using single-cell bioluminescence resonance energy transfer microscopy, we
147 nt ternary complex with SUMO as evidenced by bioluminescence resonance energy transfer, nuclear magne
148  APJ mutants in TMD1 and TMD2 also decreased bioluminescence resonance energy transfer of APJ dimer.
149 uctor nanocrystals or quantum dots (QDs) and bioluminescence resonance energy transfer (QD-BRET) to d
150  their ability to form dimers (oligomers) in bioluminescence resonance energy transfer saturation ass
151 dies of cAMP regulation we developed a BRET (bioluminescence resonance energy transfer) sensor for cA
152                                          The bioluminescence resonance energy transfer signal exhibit
153 ruption screening for inhibition of receptor bioluminescence resonance energy transfer signal.
154                            Using a cell-free bioluminescence resonance energy transfer strategy we co
155                   Co-immunoprecipitation and bioluminescence resonance energy transfer studies confir
156                                              Bioluminescence resonance energy transfer studies showed
157                                     Finally, bioluminescence resonance energy transfer studies with b
158               We recently proposed, based on bioluminescence resonance energy transfer studies with t
159 n of the split HuR luciferase assay with the bioluminescence resonance energy transfer technique sugg
160            Using a split luciferase assay, a bioluminescence resonance energy transfer technique, and
161 nd biophysical studies, including the use of bioluminescence resonance energy transfer technology, su
162 r fractionation, co-immunoprecipitation, and bioluminescence resonance energy transfer that combined
163                           The intramolecular bioluminescence resonance energy transfer that occurs be
164                                 Here we used bioluminescence resonance energy transfer to monitor inh
165                                        Using bioluminescence resonance energy transfer to monitor rec
166                                      We used bioluminescence resonance energy transfer to show that C
167 r ratio required to reach half-maximal BRET [bioluminescence resonance energy transfer] values) showe
168    Galpha(i)-dependent and agonist-sensitive bioluminescence resonance energy transfer was also obser
169                                              Bioluminescence resonance energy transfer was employed t
170 ing a novel reporter based on intramolecular bioluminescence resonance energy transfer, we have deter
171                              Using live cell bioluminescence resonance energy transfer, we show that

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。
 
Page Top
コーパス検索結果について
ご利用ガイド
ご利用規定
新規対訳・お問い合わせ
Copyright 1993 - ライフサイエンス辞書プロジェクト